Disparities in Maternal-Infant Drug Testing
More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.
A New Study Investigates the Impact of a Drospirenone-Only Contraceptive Pill On Postpartum Mood
Postpartum women taking a drospirenone-only contraceptive pill experienced a decrease in depressive symptoms.
Using Predictive Modeling to Examine IV Ketamine and Esketamine for the Prevention of Postpartum Depression
Intravenous ketamine or esketamine given at the time of cesarean delivery reduced risk for postpartum depression; predictive models are needed to determine which women are most likely to benefit from this intervention.
Weekly Roundup for August 4, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Weekly Roundup for July 28, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
For PMDD, Does Symptom-Onset Dosing of an SSRI Work?
Symptom-onset dosing with a serotonin reuptake inhibitor for PMDD may have a greater impact on anger/irritability and relationship functioning than other symptoms.
Weekly Roundup for July 14, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Postpartum Psychosis: Identifying Population-Level Risk FactorsÂ
Women with medical, psychiatric, and obstetric risk factors should be closely followed within pregnancy and the postpartum.
Mandatory Signs Describing the Risks of Cannabis Use During Pregnancy: Do They Work?
Mandatory warning sign policies were not associated with reduced cannabis use during pregnancy, nor did they shift opinions regarding risk among those using cannabis prior to pregnancy.
Post-Marketing Safety Data for Brexanolone (Zulresso)
In this postmarketing surveillance data analysis, excessive sedation and loss of consciousness when receiving brexanolone occurred at lower rates than previously reported in clinical trials.